Journal of Applied Pharmacy
Open Access
ISSN: 1920-4159
+44 1300 500008
ISSN: 1920-4159
+44 1300 500008
Aaron M Tejani
Lower Mainland Pharmacy Services, Heather Pavilion Level D,
2733 Heather St. Vancouver, B.C. V5Z 1M9
Canada
Review Article
5-Alpha Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia:
A Systematic Review and Meta-Analysis
Author(s): Jennifer EJ Jun, Angus TV Kinkade, Anthony CH Tung and Aaron M TejaniJennifer EJ Jun, Angus TV Kinkade, Anthony CH Tung and Aaron M Tejani
Introduction: Finasteride and dutasteride are competitive inhibitors of 5-alpha reductase (5AR) enzymes and are commonly used for the treatment of symptomatic benign prostatic hyperplasia (BPH). This study is intended to evaluate the literature regarding the relative efficacy of these two agents on clinically important outcomes. Method: Randomized control trials, quasi-randomized trials, and systematic reviews comparing finasteride to dutasteride either as monotherapy or in combination with alpha-blockers in men with BPH were included. The outcomes studied included need for prostate-related surgery, acute urinary retention episodes, withdrawal due to adverse events, total serious adverse events, mortality, and sexual dysfunction. Results: There were no differences in need for prostate-related surgery (OR 2.01, 95% CI: 0.18, 22.24), acute urinary retention episodes (OR 1.47, 95% CI: 0... View More»
DOI:
10.4172/1920-4159.1000204